Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
Análisis de las consecuencias en materia de costos del uso preferencial del secukinumab en comparación con el adalimumab para el tratamiento de la artritis psoriásica
Alberto Jiménez-Moralesa, Rafael Cáliza, Susana Aceitunob, Miriam Pradesb, Carles Blanchc,
Corresponding author
carles.blanch@novartis.com

Corresponding author.
a Virgen de las Nieves University Hospital, Granada, Spain
b Outcomes’10, Castellón de la Plana, Spain
c Novartis Pharmaceuticals, Novartis Farmacéutica, Barcelona, Spain
Read
4188
Times
was read the article
2983
Total PDF
1205
Total HTML
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 13 14 27
2024 March 30 29 59
2024 February 21 30 51
2024 January 23 30 53
2023 December 34 27 61
2023 November 57 67 124
2023 October 46 41 87
2023 September 142 55 197
2023 August 153 22 175
2023 July 27 2184 2211
2023 June 27 34 61
2023 May 29 35 64
2023 April 16 22 38
2023 March 48 25 73
2023 February 40 25 65
2023 January 24 15 39
2022 December 61 37 98
2022 November 61 36 97
2022 October 85 33 118
2022 September 65 40 105
2022 August 66 40 106
2022 July 46 45 91
2022 June 44 40 84
2022 May 47 55 102
2022 February 0 2 2
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?